Xanthelasma Palpebrarum.
Al Aboud AM, Shah SS, Blair K, Al Aboud DM.
2024 Mar 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Xanthelasma: An Update on Treatment Modalities.
Laftah Z, Al-Niaimi F.
J Cutan Aesthet Surg. 2018 Jan-Mar;11(1):1-6. doi: 10.4103/JCAS.JCAS_56_17.
Xanthelasma palpebrarum - a brief review.
Nair PA, Singhal R.
Clin Cosmet Investig Dermatol. 2017 Dec 18;11:1-5. doi: 10.2147/CCID.S130116. eCollection 2018.
Xanthelasma palpebrarum.
Parkes ML, Waller TS.
Laryngoscope. 1984 Sep;94(9):1238-40. doi: 10.1288/00005537-198409000-00019.
Familial Hypercholesterolemia.
Ison HE, Clarke SL, Knowles JW.
2014 Jan 2 [updated 2025 Jan 30]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
Delayed Complications following Dermal Filler for Tear Trough Augmentation: A Systematic Review.
Trinh LN, McGuigan KC, Gupta A.
Facial Plast Surg. 2022 Jun;38(3):250-259. doi: 10.1055/s-0041-1736390. Epub 2021 Oct 19.
Necrobiotic Xanthogranuloma.
Dellatorre G, Miqueloto JK.
JAMA Dermatol. 2020 Jun 1;156(6):696. doi: 10.1001/jamadermatol.2020.0897.
Xanthelasma-Like Reaction to Filler Injection.
Or L, Eviatar JA, Massry GG, Bernardini FP, Hartstein ME.
Ophthalmic Plast Reconstr Surg. 2017 Jul/Aug;33(4):244-247. doi: 10.1097/IOP.0000000000000722.
Editorial.
Goldberg DJ Md Jd.
J Cosmet Laser Ther. 2017 Apr;19(2):75. doi: 10.1080/14764172.2017.1293967.
Examining treatment strategies for xanthelasma palpebrarum: a comprehensive literature review of contemporary modalities.
Yee DA, Zhou AE, Khachemoune A.
Arch Dermatol Res. 2024 May 9;316(5):149. doi: 10.1007/s00403-024-02863-y.
